According to Gram Research analysis, newly diagnosed type 2 diabetes patients show a strong connection between higher blood sugar levels and greater variation in red blood cell sizes. A 2026 cross-sectional study of 202 untreated diabetes patients found that HbA1c levels explained 32% of the variation in red blood cell size differences, with this relationship remaining strong even after adjusting for age, weight, nutrition, and kidney function. However, researchers emphasize these are preliminary findings that don’t yet establish red blood cell variation as a practical clinical tool for managing diabetes.
Researchers discovered that people newly diagnosed with type 2 diabetes show a connection between their blood sugar control (measured by HbA1c) and the variation in their red blood cell sizes (RDW-SD). In a study of 202 adults with newly diagnosed diabetes who hadn’t started treatment yet, scientists found that higher blood sugar levels were linked to greater differences in red blood cell sizes. This relationship stayed strong even after accounting for other health factors like nutrition and kidney function. While these findings are interesting, researchers emphasize this is early-stage work that doesn’t yet prove red blood cell variation is a reliable way to measure diabetes control.
Key Statistics
A 2026 cross-sectional study of 202 newly diagnosed, untreated type 2 diabetes patients found a strong positive correlation (r = 0.664, p < 0.001) between blood sugar levels (HbA1c) and red blood cell size variation (RDW-SD).
In the same 202-patient study, blood sugar levels explained 32.3% of the variation in red blood cell size differences, making HbA1c the strongest predictor of red blood cell variation in the analysis.
Patients in the highest blood sugar group showed red blood cell size variation of 46.13 fL compared to 40.40 fL in the lowest group—a 5.7 fL difference—demonstrating a clear stepwise increase across blood sugar levels.
The association between blood sugar and red blood cell variation remained essentially unchanged (partial r = 0.662) even after adjusting for age, weight, hemoglobin, kidney function, iron stores, and vitamin B12 levels in the 202-patient study.
The Quick Take
- What they studied: Whether blood sugar levels (HbA1c) in newly diagnosed type 2 diabetes patients are connected to how much variation exists in the size of their red blood cells (RDW-SD).
- Who participated: 202 adults aged 18-65 years with newly diagnosed type 2 diabetes who hadn’t started any diabetes medications yet. The study excluded people with anemia, kidney problems, active infections, or blood disorders.
- Key finding: Higher blood sugar levels showed a strong connection with greater variation in red blood cell sizes. This relationship remained strong even after adjusting for age, weight, nutrition, and kidney function. Blood sugar levels explained about 32% of the variation in red blood cell size differences.
- What it means for you: This research suggests red blood cells may respond to high blood sugar in measurable ways. However, researchers caution this is preliminary work—it doesn’t yet prove that measuring red blood cell variation is a practical tool for managing diabetes. Talk to your doctor about established methods for tracking blood sugar control.
The Research Details
This was a retrospective cross-sectional study, meaning researchers looked back at medical records from 202 people with newly diagnosed type 2 diabetes seen at a hospital between September 2024 and January 2026. They examined the relationship between HbA1c (a three-month average of blood sugar levels) and RDW-SD (a measurement of how much red blood cell sizes vary). The researchers carefully excluded people with conditions that could affect red blood cell measurements, like anemia or recent blood transfusions, to ensure the results reflected only the diabetes-blood cell relationship.
The scientists used several statistical methods to test their findings. They started with simple correlation analysis to see if the two measurements moved together. Then they used more advanced techniques that adjusted for other factors that might influence red blood cell size, such as age, weight, hemoglobin levels, kidney function, iron stores, and vitamin B12 levels. Finally, they used hierarchical regression analysis to determine which factors were most important in explaining red blood cell variation.
The researchers also tested whether their findings held up when they added fasting glucose measurements to their analysis. This sensitivity analysis helps confirm that the relationship between blood sugar and red blood cell variation is real and not dependent on just one way of measuring blood sugar.
This research approach is important because it focuses on people with newly diagnosed, untreated diabetes. This means the researchers could study the pure relationship between high blood sugar and red blood cell changes without interference from diabetes medications. By carefully excluding people with other conditions affecting red blood cells, they isolated the diabetes effect. The use of multiple statistical methods strengthens confidence in the findings by showing the relationship persists even after accounting for many other health factors.
Strengths of this study include its careful patient selection (excluding confounding conditions), use of multiple statistical approaches, and sensitivity analyses that tested whether findings held up under different conditions. The study was conducted at a tertiary university hospital, suggesting access to quality laboratory measurements. Limitations include the relatively small sample size (202 people), the cross-sectional design (which shows association but not cause-and-effect), and the lack of diversity information about the participants. The researchers themselves note these are hypothesis-generating findings that require further research before clinical application.
What the Results Show
The study found a strong positive correlation between HbA1c and RDW-SD, with a correlation coefficient of 0.664 (p < 0.001). This means as blood sugar levels increased, red blood cell size variation increased in a consistent pattern. Importantly, this relationship remained nearly identical (0.662) even after adjusting for age, sex, body mass index, hemoglobin, mean corpuscular volume, kidney function markers, iron stores, and vitamin B12 levels. This suggests the connection between blood sugar and red blood cell variation is independent of these other factors.
When researchers divided participants into three groups based on their HbA1c levels (low, medium, and high), they found a clear stepwise increase in red blood cell size variation. The lowest blood sugar group had an average RDW-SD of 40.40 fL, the middle group was 42.96 fL, and the highest group was 46.13 fL (p-trend < 0.001). This means the highest blood sugar group had red blood cells that varied about 5.7 fL more in size than the lowest group—a substantial difference.
In the hierarchical regression analysis, HbA1c was the strongest predictor of red blood cell size variation. It explained 32.3% of the variation in RDW-SD on its own (ΔR² = 0.323), which was more than any other factor tested. Even in the fully adjusted model that included all other health measurements, HbA1c remained the strongest correlate, with a standardized coefficient of 0.674. When fasting glucose was added to the analysis, the association between HbA1c and RDW-SD remained essentially unchanged, confirming the robustness of the finding.
The study’s careful exclusion criteria and sensitivity analyses revealed that the HbA1c-RDW-SD relationship is not explained by anemia, abnormal red blood cell sizes from other causes, kidney disease, inflammation, or nutritional deficiencies. This specificity strengthens the argument that high blood sugar itself drives the increase in red blood cell size variation. The fact that the relationship persisted after adjustment for fasting glucose suggests that the three-month average blood sugar level (HbA1c) captures something important about the chronic blood sugar exposure that affects red blood cells.
Red cell distribution width has previously been linked to inflammation, oxidative stress, and metabolic dysfunction in various conditions. This study extends that understanding by showing a specific, strong relationship between blood sugar control and red blood cell size variation in newly diagnosed type 2 diabetes. The findings align with the biological plausibility that chronic high blood sugar could affect red blood cell development and lifespan. However, the researchers note that evidence on this specific relationship in untreated diabetes was previously limited, making this study a meaningful contribution to understanding how diabetes affects blood cells.
The researchers acknowledge several important limitations. First, this is a cross-sectional study, meaning it shows association but cannot prove that high blood sugar causes red blood cell changes—only that they occur together. Second, the sample size of 202 people is relatively modest, which may limit how well findings apply to larger populations. Third, the study doesn’t provide information about the diversity of participants in terms of race, ethnicity, or socioeconomic status, so it’s unclear if findings apply equally to all populations. Fourth, the study was conducted at a single tertiary hospital, which may not represent all healthcare settings. Finally, and importantly, the researchers emphasize these are hypothesis-generating findings that do not establish RDW-SD as a clinically useful marker for assessing diabetes control. Further research is needed before this measurement could be recommended for clinical practice.
The Bottom Line
Based on this preliminary research, there are no new clinical recommendations at this time. Continue using established methods for monitoring type 2 diabetes, including HbA1c testing (every 3 months for newly diagnosed patients), fasting blood glucose, and home blood sugar monitoring as directed by your healthcare provider. This research is interesting but not yet ready for clinical application. Discuss with your doctor about the best ways to monitor your individual diabetes control.
This research is most relevant to people with newly diagnosed type 2 diabetes, their healthcare providers, and diabetes researchers. People with established diabetes on treatment should continue their current monitoring approach. Healthcare providers may find this work interesting for understanding how diabetes affects blood cells, but it doesn’t change current clinical practice. Researchers studying diabetes complications and blood cell changes will likely build on these findings.
This is early-stage research, so there’s no timeline for practical benefits yet. The findings are hypothesis-generating, meaning they suggest directions for future research rather than providing immediate clinical tools. If this research leads to further studies confirming these findings, it could take several years before any new clinical applications emerge. In the meantime, people with type 2 diabetes should focus on proven management strategies.
Frequently Asked Questions
What is the connection between blood sugar and red blood cell size variation?
A 2026 study of 202 newly diagnosed diabetes patients found that higher blood sugar levels (HbA1c) are strongly associated with greater variation in red blood cell sizes. This relationship remained strong even after accounting for other health factors, suggesting high blood sugar may directly affect how red blood cells develop.
Can doctors use red blood cell variation to measure diabetes control?
Not yet. While this research shows an interesting connection, the researchers specifically state these findings are preliminary and don’t establish red blood cell variation as a clinical tool for assessing diabetes. More research is needed before this measurement could be recommended for routine diabetes monitoring.
Does this research change how I should monitor my type 2 diabetes?
No. Continue using established monitoring methods like HbA1c testing every three months and home blood glucose monitoring as directed by your doctor. This research is hypothesis-generating work that may inform future clinical tools, but it doesn’t change current best practices.
Why did researchers study red blood cell size in diabetes patients?
Red blood cell size variation has been linked to inflammation and metabolic problems in various conditions. Researchers wanted to understand whether this marker responds to high blood sugar in newly diagnosed diabetes patients, which could eventually help explain how diabetes affects blood cells.
How strong is the relationship between blood sugar and red blood cell variation?
The correlation is strong (0.664 on a scale where 1.0 is perfect), and blood sugar levels explained about 32% of red blood cell size variation. This is a substantial relationship, but it means other factors account for the remaining 68% of variation.
Want to Apply This Research?
- Track your HbA1c results every three months (or as recommended by your doctor) alongside your average blood glucose readings. Note the date, HbA1c percentage, and average daily glucose to see your personal trend over time.
- Use the app to set reminders for regular HbA1c testing appointments and to log your test results. Create a simple graph showing how your HbA1c changes over months, which can motivate you to maintain healthy eating and activity habits.
- Over 6-12 months, track whether your HbA1c improvements correlate with your daily glucose patterns and lifestyle changes. This personal data helps you understand what habits most effectively control your blood sugar, even though red blood cell measurements aren’t yet part of standard monitoring.
This research is preliminary and hypothesis-generating. The findings do not establish red blood cell variation as a clinical marker for diabetes assessment or management. If you have type 2 diabetes or suspect you may have diabetes, consult with your healthcare provider about appropriate screening, diagnosis, and treatment. Do not use this information to replace medical advice from your doctor. This article summarizes research findings and does not constitute medical advice or endorsement of any diagnostic or treatment approach.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.